A Generic whole-body PBPK model
A general introduction to PBPK modeling can be found, e.g., in 1,2 . Our generic whole-body PBPK model for small molecule drugs comprised 13 compartments representing important tissues/organs within the human body (see Figure 6 ).
In the sequel, we used the term 'tissue' (subscript 'tis') to jointly refer to tissues and organs. In a generic setting, we assumed that the drug distributes within the body via advection of the blood flow and via passive diffusion homogeneously into organs and tissues, and that the drug is metabolized in the liver. In the presence of more specific information, the generic PBPK model can be adapted accordingly. 
A.1 Model equations.
Based on the perfusion-limited tissue model, the following system of differential equations described the rate of change of the total drug concentration C tis in the different tissues (see Table 4 for abbreviations):
V tis d dt C tis = Q tis · C art − C tis K tis (45) tis = adi; bra; gut; hea; kid; mus; ske; ski; spl
Above, V tis and Q tis denote the tissue volume and blood flow, respectively. K tis denotes the corresponding tissue-to-blood partition coefficient and C in,tis represents the inflowing blood concentration. where the first sum is taken over spleen, gut and the arterial hepatic vein, while the second sum is taken over adipose, skeleton, brain, heart, kidneys, muscle, skin and the liver. For an i.v. bolus administration, the initial condition C(t = 0)
for the system of ODEs is set to C ven (0) = dose/V ven and C tis (0) = 0 otherwise. 
A.2 Parameterization of reference individuals.
For adults and children, tissue weights were extracted from the report of the International Commission of Radiological Protection (ICRP report) 4 . The adipose compartment was identified with the separable adipose tissue while the muscle compartment was identified with the total skeletal muscle. The gut was identified with the sum of the small intestine wall, large intestine wall, left and right colon, and rectosigmoid wall. The skeleton was identified with total skeleton, including bone and bone marrow. The considered tissues accounted for 92.6, 92.6, 93.6/93.4, 93.4/92.1 % of total body weight for children of age 5y, 10y, 15y (male/female) and adults (male/female), respectively.
Blood flow rates were taken from 4 . Unfortunately only adult data are reported (for children, only cardiac output is reported). In 5 , age-dependent perfusion per gram cerebral tissue is reported. For kidney, a value of 4.1 ml/min per g tissue independent of age is reported 6 . These values were scaled to abf Some PBPK models assume that only the unbound concentration in the liver C u,liv can be metabolized, resulting in a term CL int C u,liv instead of CL int C liv . Assuming that C u,liv = fu liv C liv , this can easily be integrated in our setting by changing CL int to CL int fu liv , where fu liv is the fraction unbound of the drug in the liver. solute blood flow rates based on the tissue weights. For the remaining tissues no reliable reports on blood flows in children were available. We therefore applied the approach described in 7 to obtain the missing values: In short, in a first step adult perfusion rates per kg tissue were scaled to children based on tissue weight. As expected, the resulting sum of tissue flows into the venous compartment is lower than the cardiac output, since tissue-weight normalized peripheral blood flow rates are usually higher in children than in adults. This reflects the higher energy expenditure due to growth. Therefore, in a second step, tissue blood flows were normalized with an age-specific normalization con- scale all blood flow rates to match the cardiac output; or include a rest of body compartment. For adults, the hematocrit value was determined by dividing red blood cell volume by total plasma volume as reported in the ICRP report 4 . For children, due to a lack of data in the ICRP report, we adopted the hematocrit value of adults. Table 3 summarizes all age-dependent anthropometric data.
A.3 Drug-related parameters.
For a diverse collection of 25 drugs with different physico-chemical properties parameters are given in Table 3 in 3 . These include (i) drug-specific parameters: pK a value, n-octanol-buffer partition coefficient logP ow ; and (ii) mixed drug-age/sex related parameters: fraction unbound in plasma fuP, blood-toplasma ratio BP, tissue-to-blood partition coefficients K tis , and blood clearance CL blood . In the sequel, we outlined how to account for parameter dependencies on age and sex. Since not all those data are typically available for a given compound, we subsequently simplified the relationships including only typically available data.
Given sex and age dependent changes in binding protein concentrations, the fraction unbound in plasma fuP was considered a potentially age/sex dependent parameter. It was assumed that BP was measured in healthy male adults (ad/m). Using this values we determined the erythrocyte-to-unbound plasma
Assuming Ku e to be age/sex-independent, we determined the age/sex-specific blood-to-plasma ratio for other age classes by
The age/sex-dependent tissue-to-blood partition coefficients K tis were determined from the relation
where we assumed that the tissue-to-unbound plasma partition coefficients Ku tis are age/sex independent. Ku tis -values were predicted based on the in silico method proposed in Rodgers et al. 8, 9 (including the proposed correction for residual blood).
In clinical studies and classical compartment analyses, typically the blood clearance CL blood is reported. As for the blood-to-plasma ratio, we assumed that this value was measured in healthy male adults g . Under the assumption that elimination is only hepatic, we determined the intrinsic clearance per kg liver weight by
Since healthy male adults are typically enrolled for first-in-human clinical trials, where for the first time drug-related in vivo data in human are reported. 
and finally the hepatic extraction ratio
and blood clearance
In the sequel, we omitted the subscript '(age/sex)' to simplify notation whenever possible. We used Lidocaine 10 , an anti-arrhythmic drug in the treatment of ventricular arrhythmias, for illustration purpose.
A.4 Scaling of cardiac output
For the reference individuals, we expressed the blood flow in each organ as a fraction of the cardiac output. In the following, we assumed that these fractions . The hematocrit values for children were set to the corresponding adult hematocrit value in line with the NHANES study 13 .
are constant within each age class. Therefore, for an individual, the blood flow in each organ scaled according to the scaling of the cardiac output. In the following, we present the derivation of a scaling factor for the cardiac output.
The cardiac output was defined as
with stroke volume V S and heart rate HR 15 . The stroke volume was related to the end diastolic volume V ED according to Starling's Law of the Heart 16 . It states that for a constant heart rate the end diastolic volume increases with the volume of blood ejected during systolic contraction, i.e., the stroke volume, and vice-versa. The ratio of stroke volume to end diastolic volume is defined by the ejection fraction EF 15 :
In resting subjects, EF is a constant ratio of approximately 0.6 17 . Assuming Table 4 : Reference anatomical and physiological data for children and young adolescents of age five, ten, and 15 years as well as adults 
and
Exploiting the definition of the ejection fraction and EF = EF ref yielded for the stroke volume
Since amongst healthy, untrained subjects, the heart rates are approximately equal independent of body weight or body height 18 , we obtained
Therefore, the blood flow scaling factor SQ tis was shown to be equal to SV tis . The above derivation is supported by a number of observations: Combining eq. (59) with eq. (12), we inferred that the cardiac output is approximately scaled with LBW. Under physiological aspects this scaling is reasonable since LBW represents body compartments with high metabolic demands and therefore high oxygen consumption 19, 20 . The larger LBW, the more oxygen needs to be transported into the respective tissues. Therefore a higher blood flow and cardiac output are required. Furthermore, the scaling of the left ventricular volume with the formerly derived SV tis (see eq. (12)) is supported by 19, 21, 22 who observed a relation between LBW and left ventricular volume. Finally, for obese individuals it is reported in 18 that an increase in cardiac output is only due to an increase in stroke volume. 
where OW ref denotes the organ weight of the reference individual with LBW ref .
For illustration, we applied the above transformation to the liver weight and compared it to the regression equation obtain by Heinemann et al. 24 in adults and a density of 1g/mL). This is very similar to the regression equation (62) reported by Heinemann et al. 24 .
While the LBW-scaling approach is based on mechanistic considerationsand thereby not tight to a specific study population-, the parameters of any regression equation are related to the specific population used to derive it. For example, in 25 , a completely different regression equation V liv = 0.722 · BSA
1.176
is presented based on the Heinmann et al. data that were enriched by additional experimental data.
C Generic compartment models with mechanistically integrated covariates
We applied the mechanistic approach to covariate modeling to derive a 1-compartment model with mechanistic covariate models that are consistent with the generic whole-body PBPK model and inter-individual variability based on the LBW-scaling approach.
1-compartment model. We obtained
with mechanistic covariate model
with the scaling factors defined in eq. (23) . The population parameters Θ k obeyed the following functional relationship to the parameters of the PBPK model:
Θ CL = CL blood,ref .
Thus, Θ 1 denotes the volume of distribution associated with the LBW, i.e., associated with all tissues except for adipose, while Θ adi denotes the volume of distribution associated with the adipose tissue. Consequently, the volume of distribution V ss,ref is given by
The parameter Θ CL is identical to the reference blood clearance CL blood,ref . Finally, the organ weight of adipose is defined as the difference of BW and the sum over all scaled, non-adipose organ/tissues weights
The cardiac output is scaled as
Tissue blood flows were derived from the cardiac output by assuming a constant fraction of tissue blood flow to cardiac output.
Remark. To generate a virtual population of predefined BH and BW distribution, the above BH-scaling approach is only considered the first (deterministic) step. These values are then randomly perturbed in a second, stochastic 
D.3 Allometric scaling.
A common approach for extrapolation of classical compartment models from adults to children is based on allometric scaling see, e.g., 27 and references therein. Most body size relations take the form
where Y is the biological characteristic to be predicted, BW is the body weight, and a and b are empirically derived constants. Following Table 1 
E Virtual populations and uncertainty in partition coefficients E.1 Algorithm for Creating a Virtual Population.
We assumed that BH is normally distribution with mean µ BH and standard deviation σ BH , i.e.,
We further assume that BMI is log-normally distribution with parameters µ BMI and σ
Both assumptions are in line with the NHANES study 13 . In this study, the difference between a normal and a log-normal distribution for BH of Caucasians is negligible; so alternatively, one might also assume a log-normal distribution for BH. In the NHANES study, BH and BMI are only very weakly correlated, so assuming these two covariates as uncorrelated seems a reasonable approximation.
To generate a virtual population in terms of N pairs of (BH, BW) of a given sex, we required the parameters µ BH , σ BH , µ BMI and σ BMI as input. We proceeded as follows to generate a single pair of BH and BW:
1. We sampled a BH value from N (µ BH , σ 2 BH ).
2. We sampled a BMI value from lnN (μ BMI ,σ 2 BMI ). If only a descriptive statistics on BMI was available (rather than on log BMI), we sampled a transformed BMI value from the normal distribution N (μ BMI ,σ 
where µ BMI and σ BMI denote the mean and standard deviation of the descriptive statistics. Finally, we set BMI = exp( BMI).
3. Finally, we determined BW according to BW = BH 2 · BMI.
We repeated the above steps N times. For example, to create a virtual population with the characteristics of the autopsy study 11 listed in Table 2 between BH and BW, as observed in the NHANES study 13 .
Given the ensemble of N individual (BH, BW) pairs, we used the LBWscaling approach together with the parameters of the reference adult (Table 3+4) and the compound specific input (Table 3 in 3 ) to generate all parameters required to parameterize the generic PBPK model.
E.2 Algorithm to include uncertainty in predicting tissue
partition coefficients.
For a given uncertainty factor UF and tissue-to-blood partition coefficients K tis , the algorithm proceeds as follows to compute the perturbed tissue-to-blood partition coefficient K tis :
1. Choose two random numbers α, ξ ∼ U (0, 1] uniformly in the interval (0, 1].
2. Then, K tis is defined as
3. Repeat for all partition coefficients K tis .
The above procedure aims at resembling the statement about the accuracy of the in silico predicted partition coefficients in 8, 9 that 84%-89% of the predicted tissue-to-unbound plasma partition coefficients are within a factor of three of experimentally determined values.
